Unregistered Sales of Equity Securities and Use of Proceeds
−Removed: (a) Sales of Unregistered Securities
−Removed: From July 1, 2024 through September 30, 2024, we granted stock options to purchase an aggregate of 4,408,100 shares of our common stock at a weighted-average price of $17.00 to employees, directors and consultants.
−Removed: Since July 1, 2024 through September 30, 2024, 3,263 shares of our common stock have been issued upon the exercise of stock options at a weighted-average exercise price of $9.30.
−Removed: No underwriters were involved in the sales of the above securities and such issuances were exempt either pursuant to Rule 701, as transactions pursuant to compensatory benefit plan, or pursuant to Rule 4(a)(2), as transactions by an issuer not involving a public offering.
(b) Use of Proceeds from Public Offering of Common Stock
−Removed: The offer and sale of shares in our IPO were registered under the Securities Act pursuant to a registration statement on Form S-1 (File No.
−Removed: 333-281713), which was declared effective by the SEC on September 12, 2024 and a registration statement on Form S-1MEF (File No.
−Removed: 333-282082), which was automatically effective upon filing with the SEC on September 12, 2024.
−Removed: Following the sale of all of the shares offered in connection with the closing of our IPO, the offering terminated.
−Removed: Morgan Stanley & Co.
−Removed: LLC, Jefferies LLC, Citigroup Global Markets Inc.
−Removed: and Guggenheim Securities, LLC acted as joint book-running managers for the IPO.
−Removed: We received aggregate gross proceeds from our IPO of $258.7 million, or aggregate net proceeds of $240.6 million after deducting underwriting discounts and commissions but before deducting other offering costs payable by us, which we estimate to be $6.2 million.
−Removed: None of the underwriting discounts and commissions or offering expenses were incurred or paid, directly or indirectly, to directors or officers of ours or their associates or to persons owning 10% or more of our common stock or to any of our affiliates.
+Added: On September 16, 2024, the Company’s registration statement on Form S-1 (File No.333-281713) (the “IPO Prospectus”) relating to our IPO became effective.
There has been no material change in the planned use of proceeds from our IPO from that described in the IPO Prospectus.
−Removed: (c) Issuer Purchases of Equity Securities
Defaults Upon Senior Securities
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.